AHK-Cu (Alanyl-L-Histidyl-L-Lysine:Copper) is a synthetic copper tripeptide engineered specifically for hair follicle research — and it holds a unique position in the copper peptide landscape because it has the most direct published evidence for hair follicle stimulation of any copper peptide studied to date.

AHK-Cu (Alanyl-L-Histidyl-L-Lysine:Copper) is a synthetic copper tripeptide engineered specifically for hair follicle research — and it holds a unique position in the copper peptide landscape because it has the most direct published evidence for hair follicle stimulation of any copper peptide studied to date. While its structural cousin GHK-Cu has a broader body of research spanning wound healing, skin regeneration, and gene expression modulation across 4,000+ genes, AHK-Cu’s published data is focused precisely on the tissue researchers studying hair biology care most about: dermal papilla cells and hair follicles.

The landmark 2007 study by Pyo et al. at Seoul National University demonstrated that AHK-Cu stimulated the elongation of human hair follicles in ex vivo organ culture, increased dermal papilla cell proliferation at picomolar to nanomolar concentrations, and upregulated vascular endothelial growth factor (VEGF) expression — the growth factor most critical for perifollicular blood supply. PSPeptides offers AHK-Cu alongside GHK-Cu, the GHK-Cu Spray, and the GHK-Cu Skin Serum — providing researchers with both copper peptide variants for comparative studies and complementary protocol design.

What Is AHK-Cu and How Does It Differ from GHK-Cu?

AHK-Cu and GHK-Cu are both copper tripeptide complexes — three amino acids coordinated with a copper(II) ion. The structural difference is a single amino acid substitution at the first position: GHK-Cu uses glycine (Gly-His-Lys:Cu²⁺), while AHK-Cu uses alanine (Ala-His-Lys:Cu²⁺). This seemingly minor change — replacing glycine’s hydrogen side chain with alanine’s methyl group — alters the peptide’s binding characteristics, tissue affinity, and research profile in meaningful ways.

GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine, with plasma levels that decline from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. Its research profile is extraordinarily broad — published genomic studies show GHK-Cu modulates over 4,000 human genes related to collagen synthesis, wound healing, anti-inflammation, and antioxidant defense. GHK-Cu is the copper peptide most referenced in dermatology reviews and wound healing literature.

AHK-Cu is synthetic — it does not occur naturally in human tissue. It was designed as a structural analogue of GHK-Cu with the hypothesis that the alanine substitution might provide different or enhanced biological activity in specific tissues. Published research has confirmed this hypothesis specifically for hair follicle biology: AHK-Cu has the most direct published evidence for hair follicle effects, while GHK-Cu has the broader regenerative biology across multiple tissue types. Understanding this distinction is essential for researchers choosing between them — or deciding to use both.

What Does the Published Research Show About AHK-Cu and Hair Growth?

The foundational study for AHK-Cu’s hair growth effects was published by Pyo et al. in Archives of Pharmacal Research in 2007. This study used two experimental systems — dermal papilla cell (DPC) cultures and ex vivo human hair follicle organ culture — to evaluate AHK-Cu’s effects on the cellular and structural components of hair growth.

Dermal papilla cell proliferation: The dermal papilla (DP) is the mesenchymal signaling center at the base of each hair follicle. DP cells produce the growth factors that drive follicular cycling, determine hair shaft diameter, and maintain the anagen (growth) phase of the hair cycle. When DP cells lose their inductive capacity — as occurs in androgenetic alopecia (pattern hair loss) — follicles miniaturize and eventually produce only vellus (fine, unpigmented) hairs. The Pyo study demonstrated that AHK-Cu increased DPC proliferation at concentrations ranging from picomolar to nanomolar — remarkably low concentrations suggesting high biological potency for this specific cell type.

Hair follicle elongation: Using ex vivo human hair follicle organ culture — isolated hair follicles maintained in culture medium outside the body — the researchers showed that AHK-Cu treatment extended follicle length, consistent with promoting the anagen phase of hair growth. This ex vivo model is significant because it uses actual human hair follicles rather than cell cultures or animal models, providing direct evidence of effects on intact human follicular structures.

VEGF upregulation: AHK-Cu increased the expression of vascular endothelial growth factor (VEGF) in dermal papilla cells. VEGF drives angiogenesis — the formation of new blood vessels — and perifollicular vascularization is critical for follicle health. Each hair follicle requires adequate blood supply to deliver oxygen, nutrients, and hormonal signals during the metabolically demanding anagen growth phase. Follicle miniaturization in androgenetic alopecia is associated with reduced perifollicular vascularization, and interventions that increase VEGF expression may help maintain the blood supply that follicles need to sustain robust growth.

Anti-apoptotic effects: The study also documented that AHK-Cu reduced apoptosis (programmed cell death) in dermal papilla cells — suggesting a protective effect that may help prevent the DP cell loss associated with follicle miniaturization. The same research group at Seoul National University had previously used identical DPC models to study minoxidil (the only FDA-approved topical hair loss treatment), finding similar proliferative and anti-apoptotic mechanisms — placing AHK-Cu’s effects in the context of established hair biology research methodologies.

AHK-Cu vs GHK-Cu for Hair Research: Which Should You Use?

This is the most common question researchers ask when comparing these two copper peptides for hair biology applications. The answer depends on the research question and whether the protocol targets hair specifically or addresses broader tissue regeneration that includes hair as one endpoint.

Choose AHK-Cu when: The research question is specifically about hair follicle biology — DPC proliferation, follicle cycling, anagen phase extension, or perifollicular vascularization. AHK-Cu has the most direct published evidence for these specific endpoints from the Pyo 2007 study. For hair-focused protocols, AHK-Cu provides the most evidence-supported intervention for the target tissue.

Choose GHK-Cu when: The research question involves broader skin and tissue regeneration that includes hair as one component — wound healing, collagen synthesis, gene expression modulation, or anti-aging applications where hair growth is a secondary endpoint alongside skin quality improvement. GHK-Cu’s 4,000+ gene modulation profile provides a broader regenerative signal that includes hair-relevant genes alongside the full spectrum of tissue repair and remodeling programs. For detailed GHK-Cu mechanism and evidence, see our GHK-Cu research guide.

Use both when: The research protocol aims to maximize hair growth support through complementary mechanisms. AHK-Cu’s direct follicular effects (DPC proliferation, VEGF upregulation) and GHK-Cu’s broader regenerative gene modulation (collagen synthesis, matrix remodeling, anti-inflammatory effects) address different aspects of scalp and follicle biology. Published research has noted that many advanced hair formulations combine both copper peptides for potentially complementary benefits, though controlled studies evaluating the specific combination are limited. PSPeptides carries both AHK-Cu and GHK-Cu for researchers designing comparative or combination protocols.

The mechanistic basis for combining AHK-Cu and GHK-Cu rests on their partially non-overlapping biological activities. While both deliver copper ions to tissue and share some copper-dependent effects (lysyl oxidase activation, SOD support), their peptide-specific signaling differs. AHK-Cu’s Pyo 2007 data specifically documents DPC proliferation and VEGF upregulation in follicular tissue at picomolar concentrations — effects that may involve AHK-Cu-specific receptor or signaling interactions not shared with GHK-Cu. GHK-Cu’s 4,000+ gene modulation profile includes genes relevant to hair (collagen III, decorin, TGF-beta regulation) alongside broader wound healing and anti-aging gene programs — providing a more comprehensive regenerative signal that supports the scalp environment as a whole rather than targeting follicles specifically. For researchers comparing cosmetic peptide mechanisms, our Matrixyl vs GHK-Cu comparison covers how different peptides address skin biology through distinct molecular targets.

How Does AHK-Cu Work at the Molecular Level?

Like GHK-Cu, AHK-Cu functions as a copper delivery vehicle — the tripeptide structure binds and transports the copper(II) ion to tissue sites where copper-dependent biological processes occur. Copper is an essential trace element required as a cofactor for several enzymes directly relevant to hair and skin biology.

Lysyl oxidase: Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin fibers in the extracellular matrix. In the dermal papilla and follicular sheath, this cross-linking maintains the structural integrity of the follicle architecture that supports hair growth. Copper peptide delivery to follicular tissue may support lysyl oxidase activity and thereby maintain the structural framework within which follicles operate.

Superoxide dismutase (Cu/Zn-SOD): Copper is a component of the Cu/Zn-SOD antioxidant enzyme that protects cells from superoxide radical damage. Oxidative stress in the scalp — from UV radiation, environmental pollutants, and inflammatory processes — can damage follicular cells and contribute to premature catagen (regression phase) entry. Copper peptide delivery may support local antioxidant defense in scalp tissue.

Cytochrome c oxidase: Copper is essential for the terminal enzyme in the mitochondrial electron transport chain. Adequate copper availability supports the ATP production that metabolically demanding follicle cells require during the anagen growth phase — a period of rapid cell division that places significant energy demands on the follicle. Hair follicle matrix cells are among the most rapidly dividing cells in the human body (second only to bone marrow), with mitotic rates peaking during mid-anagen. This extraordinary proliferative activity requires correspondingly high ATP output from follicular mitochondria, making copper availability for cytochrome c oxidase function directly relevant to the energy supply that sustained hair growth demands.

The VEGF upregulation documented by Pyo et al. adds a signaling dimension beyond simple copper delivery. VEGF expression is regulated by transcription factors including HIF-1α (hypoxia-inducible factor), and copper peptides may modulate VEGF expression through effects on these transcription factors as well as through direct copper-dependent enzyme activity. The perifollicular vascular network that VEGF supports is not merely passive plumbing — it delivers the hormonal signals (androgens, thyroid hormones, growth factors) that regulate follicular cycling, making vascularization a determinant of both hair growth rate and follicle cycling phase duration.

For researchers studying VEGF-mediated angiogenesis in other contexts, BPC-157 also upregulates VEGF through a distinct mechanism — its gastric pentadecapeptide structure activates VEGF/VEGFR2 signaling independent of copper delivery.

AHK-Cu Research Protocols and Handling

PSPeptides supplies AHK-Cu as a lyophilized powder in vial format. For topical hair research applications, the peptide can be reconstituted and incorporated into topical formulations — aqueous solutions, serums, or spray vehicles designed for scalp application. For reconstitution procedures, see our reconstitution guide. For dosing calculations, our peptide calculator covers mass-to-volume conversions.

The Pyo 2007 study used AHK-Cu at picomolar to nanomolar concentrations for DPC proliferation effects — remarkably low concentrations that suggest high biological potency. For topical applications targeting the scalp, the peptide must penetrate the stratum corneum to reach the dermal papilla at the base of each follicle. AHK-Cu’s small molecular weight (approximately 400 Da) falls within the range where meaningful transdermal penetration is pharmacologically plausible, particularly on the scalp where the stratum corneum is thinner than on most body surfaces and where hair follicle openings provide additional transappendageal absorption routes.

For researchers who want the convenience of a pre-formulated topical product, PSPeptides offers the GHK-Cu Spray for ready-to-use topical copper peptide application. Researchers can combine the GHK-Cu spray with a custom AHK-Cu formulation for dual copper peptide protocols. For complete topical formulation guidance, our GHK-Cu topical serum guide covers vehicle selection, concentration optimization, and application protocols applicable to both copper peptides. The same formulation principles — pH optimization (5.0-6.5 for copper peptide stability), appropriate preservation, and penetration enhancement strategies — apply whether formulating AHK-Cu alone, GHK-Cu alone, or a combination of both copper peptides in a single topical preparation.

Storage follows standard peptide guidelines: lyophilized AHK-Cu at -20°C for long-term preservation, or 2-8°C for shorter periods. Reconstituted solutions should be refrigerated and used within 28 days. Protect from light and avoid repeated freeze-thaw cycles. For comprehensive storage protocols, see our peptide storage guide.

AHK-Cu in the Broader Hair Growth Peptide Landscape

Hair biology research in 2026 involves multiple peptides and compounds that affect follicular cycling, scalp health, and hair shaft quality through different mechanisms. Understanding where AHK-Cu fits helps researchers design comprehensive hair protocols. For a full overview, see our peptides for hair growth guide.

AHK-Cu + GHK-Cu: The most evidence-supported copper peptide combination for hair research — AHK-Cu for direct follicular stimulation and GHK-Cu for broader regenerative gene modulation including collagen synthesis, matrix remodeling, and anti-inflammatory effects in scalp tissue.

AHK-Cu + BPC-157: BPC-157 promotes angiogenesis through VEGF/VEGFR2 pathways distinct from AHK-Cu’s copper-mediated VEGF upregulation. Combining both may produce complementary vascularization support from two different molecular entry points. The BPC-157+TB-500 Spray adds TB-500’s hair follicle stem cell activation for a three-mechanism approach.

AHK-Cu + GH-class peptides: Growth hormone promotes hair growth through IGF-1-mediated effects on follicular keratinocytes. Sprays like the Ipamorelin Spray or Sermorelin Spray can be combined with topical AHK-Cu for protocols that support hair biology from both the local (copper peptide) and systemic (GH/IGF-1) sides. Our CJC-1295/Ipamorelin guide covers the GH mechanism.

Further Reading

For additional peer-reviewed research, see: AHK-Cu hair follicle study by Pyo et al. (Archives of Pharmacal Research, 2007).

Understanding ahk-cu is essential for researchers navigating this rapidly evolving field in 2026.

Frequently Asked Questions

What is AHK-Cu and how does it promote hair growth?

AHK-Cu (Alanyl-Histidyl-Lysine:Copper) is a synthetic copper tripeptide that stimulates dermal papilla cell proliferation, extends hair follicle elongation in ex vivo human follicle culture, upregulates VEGF expression for perifollicular blood supply, and reduces follicular cell apoptosis. Published data from the Pyo 2007 study at Seoul National University documented these effects at remarkably low (picomolar-nanomolar) concentrations.

What is the difference between AHK-Cu and GHK-Cu?

Both are copper tripeptides differing by one amino acid: AHK-Cu uses alanine, GHK-Cu uses glycine at the first position. AHK-Cu has the most direct published evidence for hair follicle effects specifically (DPC proliferation, follicle elongation). GHK-Cu has a broader body of research spanning wound healing, collagen synthesis, and modulation of 4,000+ genes. For hair-focused research, AHK-Cu is more specifically validated; for comprehensive skin and tissue regeneration, GHK-Cu is more extensively documented.

Can AHK-Cu and GHK-Cu be used together?

Yes, and many researchers combine them for complementary hair support. AHK-Cu provides direct follicular stimulation while GHK-Cu provides broader regenerative gene modulation. PSPeptides carries both compounds for comparative or combination protocol design. Controlled studies evaluating this specific combination are limited, but the mechanistic rationale is supported by their non-overlapping research profiles.

Is AHK-Cu applied topically or injected?

For hair research, AHK-Cu is primarily used topically — applied to the scalp surface where it penetrates to reach dermal papilla cells at the follicle base. The Pyo 2007 study used direct cell culture application. PSPeptides supplies AHK-Cu as a lyophilized powder for reconstitution into topical research formulations. Its small molecular weight (~400 Da) supports transdermal penetration through scalp skin.

All PSPeptides products are sold exclusively for research and laboratory use.